Carestream Announces Clinical Collaboration Platform
Carestream will announce a new VNA platform with advanced capabilities at RSNA 2014.
Carestream at RSNA 2014 will debut its new Clinical Data Collaboration platform that goes beyond the capabilities offered by a vendor-neutral archive (VNA), Carestream said.
This new platform helps equip the process of managing, providing, receiving, and reimbursing care with the ability to share and manage clinical data in ways that can help reduce costs and improve service delivery, Carestream said. It employs Carestream’s VNA to archive and exchange dermatology, endoscopy, radiology, and cardiology files.
Carestream announced that in an effort to allow health care departments to maintain autonomy while sharing a workflow, they will demonstrate at RSNA 2014 the data ingestion workflow via mobile devices as part of a work-in-progress linked to the Clinical Data Collaboration platform.
This new platform also provides access to specialists - enabling tele-consultancy using a zero-footprint viewer that can be embedded into the EMR. Carestream’s MyVue portal provides patients access and ability to share personal medical imaging data while Vue Beyond provides real-time business intelligence for strategic decision making.
[[{"type":"media","view_mode":"media_crop","fid":"29545","attributes":{"alt":"Carestream Clinical Data Archive","class":"media-image","id":"media_crop_169010763797","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3058","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 202px; width: 440px; border-width: 0px; border-style: solid; margin: 1px;","title":"Carestream Clinical Data Archive","typeof":"foaf:Image"}}]]
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
